Average Co-Inventor Count = 6.60
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Xencor, Inc. (25 from 216 patents)
2. Allergan, Inc. (3 from 2,285 patents)
3. Syngenta Participations Ag (1 from 1,777 patents)
4. Amgen Inc. (1,970 patents)
26 patents:
1. 12359002 - Heterodimeric antibodies that bind CD3 and tumor antigens
2. 12152076 - Bispecific and monospecific antibodies using novel anti-PD-1 sequences
3. 12129309 - Heterodimeric antibodies that bind CD3 and CD38
4. 11945880 - Heterodimeric antibodies that bind CD3 and tumor antigens
5. 11859011 - Heterodimeric antibodies that bind CD3 and tumor antigens
6. 11673972 - Heterodimeric antibodies that bind CD3 and tumor antigens
7. 11492407 - Bispecific checkpoint inhibitor antibodies
8. 11472890 - Heterodimeric antibodies that bind ENPP3 and CD3
9. 11352442 - Heterodimeric antibodies that bind CD3 and CD38
10. 11312770 - Bispecific and monospecific antibodies using novel anti-PD-1 sequences
11. 11225528 - Heterodimeric antibodies that bind CD3 and tumor antigens
12. 11111315 - Heterodimeric antibodies that bind CD3 and tumor antigens
13. 10913803 - Heterodimeric antibodies that bind CD3 and tumor antigens
14. 10889653 - Heterodimeric antibodies that bind CD3 and tumor antigens
15. 10752678 - Complement component C5 antibodies